Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial

Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial

Abstract Background Primary graft dysfunction (PGD) after lung transplantation (LuTx) contributes substantially to early postoperative morbidity. Both intraoperative transfusion of a large amount of blood products during the surgery and ischemia–reperfusion injury after allograft implantation play a...

Full description

Bibliographic Details
Main Authors: Jaromir Vajter, Jiri Vachtenheim, Zuzana Prikrylova, Jan Berousek, Tomas Vymazal, Robert Lischke, Archer Kilbourne Martin, Miroslav Durila
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Pulmonary Medicine
Subjects:
Lung transplantation
Anesthetic management
Rotational thromboelastometry
Volume replacement therapy
5% albumin
Online Access:https://doi.org/10.1186/s12890-023-02372-0

Internet

https://doi.org/10.1186/s12890-023-02372-0

Similar Items